Anavex Life Sciences Corp (AVXL)

[nidan7500]

Biostockclub, thanks for the valued feedback. Shewart (sp)the famous statistician said: " Data is worthless without context". BTW, he is the guy who did all the work for which Dr.Deming gets a lot of credit. They were both brilliant. But the point is made on process and context, which in this case may be the same thing. In this case Precision Medicine both enables and requires a technical-scientific skill set which may be already available today waiting to be properly directed by many private companies and academia. IMO, either private industry profit motivations or government funding must be added.

Sadly, the FDA are the last people on the planet to be asked to lead such a P.M. initiative, but, there it is. If we needed a bunch of rules written, then the FDA would be the place to go but we do not yet have the rules properly outlined. The Aus. A2-73 trials results will be the first example of what P.M. is capable of. P.M. rules must be politically sterile. The P.M. examples for verification and validation might be unique CNS disease indications. IMO, instead of proving that the Amyloid Thesis is valid the P.M. technical goal is to prove that CNS cellular homeostasis (restore and regen) is viable as a practice in medicine.